# HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

> **NCT07379190** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Weifang Medical University** · enrollment: 458 (estimated)

## Conditions studied

- Stroke, Acute
- Stroke, Ischemic
- Cerebral Infarction

## Interventions

- **DRUG:** Tirofiban
- **DRUG:** dual antiplatelet therapy

## Key facts

- **NCT ID:** NCT07379190
- **Lead sponsor:** Weifang Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-05-01
- **Target enrollment:** 458 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379190, "HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07379190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*